LifePoint Health, Inc. (NASDAQ:LPNT) was downgraded by analysts at TheStreet from a “b-” rating to a “c+” rating in a research report issued to clients and investors on Wednesday.

Other research analysts also recently issued research reports about the stock. ValuEngine upgraded shares of LifePoint Health from a “hold” rating to a “buy” rating in a report on Thursday. Royal Bank Of Canada restated a “buy” rating and set a $77.00 price objective on shares of LifePoint Health in a report on Wednesday, July 5th. Zacks Investment Research upgraded shares of LifePoint Health from a “hold” rating to a “buy” rating and set a $75.00 price objective on the stock in a report on Tuesday, July 4th. BidaskClub upgraded shares of LifePoint Health from a “hold” rating to a “buy” rating in a report on Friday, June 30th. Finally, Morgan Stanley initiated coverage on shares of LifePoint Health in a report on Tuesday, June 6th. They set an “equal weight” rating and a $65.00 price objective on the stock. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and six have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $66.18.

Shares of LifePoint Health (NASDAQ LPNT) traded up 1.14% during trading on Wednesday, hitting $57.45. 436,008 shares of the stock traded hands. The firm has a 50 day moving average price of $61.96 and a 200-day moving average price of $62.71. LifePoint Health has a one year low of $50.60 and a one year high of $70.95. The company has a market cap of $2.30 billion, a PE ratio of 12.86 and a beta of 0.86.

LifePoint Health (NASDAQ:LPNT) last posted its quarterly earnings data on Tuesday, August 1st. The company reported $0.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.06. LifePoint Health had a net margin of 2.61% and a return on equity of 7.40%. The company had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the previous year, the firm posted $0.69 EPS. The business’s revenue was up .2% compared to the same quarter last year. Analysts anticipate that LifePoint Health will post $4.07 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “LifePoint Health, Inc. (LPNT) Lowered to “C+” at TheStreet” was posted by American Banking News and is the property of of American Banking News. If you are accessing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2017/08/19/lifepoint-health-inc-lpnt-lowered-to-c-at-thestreet.html.

In other LifePoint Health news, Chairman William F. Carpenter III sold 17,653 shares of the business’s stock in a transaction dated Monday, July 17th. The shares were sold at an average price of $65.06, for a total value of $1,148,504.18. Following the transaction, the chairman now directly owns 439,841 shares in the company, valued at $28,616,055.46. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Chairman William F. Carpenter III sold 82,347 shares of the business’s stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $64.15, for a total transaction of $5,282,560.05. Following the completion of the transaction, the chairman now owns 504,535 shares in the company, valued at $32,365,920.25. The disclosure for this sale can be found here. 7.28% of the stock is currently owned by insiders.

Institutional investors have recently added to or reduced their stakes in the stock. Wells Fargo & Company MN raised its position in LifePoint Health by 22.6% in the first quarter. Wells Fargo & Company MN now owns 21,951 shares of the company’s stock worth $1,438,000 after buying an additional 4,045 shares during the period. Oregon Public Employees Retirement Fund raised its position in LifePoint Health by 1.4% in the first quarter. Oregon Public Employees Retirement Fund now owns 14,228 shares of the company’s stock worth $932,000 after buying an additional 200 shares during the period. DUPONT CAPITAL MANAGEMENT Corp raised its position in LifePoint Health by 3.8% in the first quarter. DUPONT CAPITAL MANAGEMENT Corp now owns 41,800 shares of the company’s stock worth $2,738,000 after buying an additional 1,512 shares during the period. Whittier Trust Co. raised its position in LifePoint Health by 5.4% in the first quarter. Whittier Trust Co. now owns 13,002 shares of the company’s stock worth $852,000 after buying an additional 662 shares during the period. Finally, Breton Hill Capital Ltd. raised its position in LifePoint Health by 10.8% in the first quarter. Breton Hill Capital Ltd. now owns 13,941 shares of the company’s stock worth $913,000 after buying an additional 1,358 shares during the period. Hedge funds and other institutional investors own 99.59% of the company’s stock.

LifePoint Health Company Profile

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Analyst Recommendations for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.